UBS Group AG - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 19 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q3 2022$14,0000.0%1,3840.0%0.00%
Q2 2022$14,000
+7.7%
1,384
+7.8%
0.00%
Q1 2022$13,000
+18.2%
1,284
+19.0%
0.00%
Q4 2021$11,000
+22.2%
1,079
+22.8%
0.00%
Q3 2021$9,0008790.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Wealthspring Capital LLC 82,283$816,0000.18%
Sage Mountain Advisors LLC 117,770$1,167,0000.14%
Mint Tower Capital Management B.V. 100,000$991,0000.13%
GLAZER CAPITAL, LLC 239,510$2,374,0000.06%
First Trust Capital Management L.P. 220,000$304,0000.05%
Schechter Investment Advisors, LLC 58,533$580,0000.05%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 30,062$298,0000.04%
ANGELO GORDON & CO., L.P. 40,000$396,0000.04%
PICTON MAHONEY ASSET MANAGEMENT 150,002$1,487,0000.04%
Magnetar Financial LLC 254,700$2,522,0000.02%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders